STOCKWATCH
·
Pharmaceuticals
Business Update28 Feb 2024, 06:12 pm

Bajaj Healthcare Ltd Enters into Definitive CDMO Agreement for 15 APIs with UK/EU Customers

AI Summary

Bajaj Healthcare Ltd, a leading manufacturer of APIs, Intermediates and Formulations, has entered into a definitive CDMO agreement with esteemed UK/EU based customers for the supply of 15 Active Pharmaceutical Ingredient (APIs).,

Key Highlights

  • Entered into definitive CDMO agreement with UK/EU customers
  • Supply of 15 APIs
  • Diverse range of compounds
  • Off-patent generics and molecules soon to be off-patent
  • State-of-the-art infrastructure
  • Exceptional quality and efficiency
BAJAJHCARE
Pharmaceuticals
Bajaj Healthcare Ltd

Price Impact